{{'Search' | translate}}
 

Prestained protein ladder

Company: Thermo Fisher
Catalog#: 26616
Bio-protocol()
Company-protocol()
Other protocol()

Affinity Purification of GO-Matryoshka Biosensors from E. coli for Quantitative Ratiometric Fluorescence Analyses
Author:
Date:
2020-10-05
[Abstract]  Genetically encoded biosensors are powerful tools for quantitative visualization of ions and metabolites in vivo. Design and optimization of such biosensors typically require analyses of large numbers of variants. Sensor properties determined in vitro such as substrate specificity, affinity, response range, dynamic range, and signal-to-noise ratio are important for evaluating in vivo data. This protocol provides a robust methodology for in vitro binding assays of newly designed sensors. Here we present a detailed protocol for purification and in vitro characterization of genetically encoded sensors, exemplified for the His affinity-tagged GO-(Green-Orange) MatryoshCaMP6s calcium sensor. GO-Matryoshka sensors are based on single-step insertion ... [摘要]  [摘要]遗传编码的生物传感器是强大的工具为离子和代谢物的定量可视化在体内。设计和优化此类生物传感器通常需要分析大量变体。体外确定的传感器特性,例如底物特异性,亲和力,响应范围,动态范围和信噪比,对于评估体内数据很重要。该协议为新设计的传感器的体外结合测定提供了可靠的方法。这里我们提出了一个详细的协议用于纯化和体外表征的遗传编码的传感器,例示的His亲和标记的GO-(绿橙色)MatryoshCaMP6s钙传感器。GO-Matryoshka传感器基于在感兴趣的结合蛋白内一步插入一个包含两个嵌套荧光蛋白,圆形排列的荧光绿色FP(cpGFP )和Large Stoke Shift LSSmOrange的盒的方法,从而产生了利用被分析物触发的比例式传感器cpGFP的荧光变化。


[背景技术]将绿色荧光蛋白(GFP)在1962年被鉴定在水母水母维多利亚(下村等人,1962) 。30年后,描述了其首次用作报道基因(Chalfie等,1994)。自从发现以来,GFP变体和其他荧光蛋白为生物科学的主要进步做出了巨大贡献,并且现在已成为生物医学研究中的常用工具(Frommer等,2009)。

各种荧光蛋白(FP)和FP变异体已被用作报道分子或与所有生命王国的生物体中的蛋白融合(Chudakov等,2010 ;Valeur和Berberan- ...

An in vitro Assay to Screen for Substrates of PKA Using Phospho-motif-specific Antibodies
Author:
Date:
2020-04-20
[Abstract]  Kinases function as regulators of many cellular processes such as cell migration. These enzymes typically phosphorylate target motif sequences. Mass spec or phospho-specific antibody detection can be used to determine whether a kinase can phosphorylate proteins of interest, however, mass spec can be expensive and phospho-antibodies for the protein of interest may not exist. In this protocol, we will describe an in vitro kinase assay to provide a preliminary readout on whether a protein of interest may be phosphorylated by PKA. Our protein of interest is purified after expression in bacteria and treated with recombinant PKA from bovine heart. Protein is then extracted and a western blot is performed using a phospho-specific antibody for PKA’s target motif. This will allow us to ... [摘要]  [摘要 ] 激酶可充当许多细胞过程(例如细胞迁移)的调节剂,这些酶通常可磷酸化靶基序序列,质谱或磷酸特异性抗体检测可用于确定激酶是否可磷酸化目标蛋白。能成为规格昂贵和磷酸化抗体蛋白的兴趣可能就不存在。在这个协议中,我们将介绍一种在体外 激酶测定法可提供有关目的蛋白是否可被PKA磷酸化的初步读数。我们的目的蛋白在细菌中表达后纯化,并用牛心脏的重组PKA处理,然后提取蛋白,并使用蛋白印迹进行蛋白质印迹磷酸化针对PKA靶标的特异性抗体,这将使我们能够快速确定PKA是否可能使我们感兴趣的蛋白质磷酸化。

[背景 ] 激素和其他因素会通过G连接的G蛋白偶联受体(GPCR)激活腺苷酸环化酶并随后促进第二信使cAMP的产生,从而影响细胞迁移等细胞过程。cAMP水平升高会导致PKA激活,丝氨酸-苏氨酸激酶在迁移细胞中肌动蛋白细胞骨架动力学的调节中起着重要作用.PKA影响肌动蛋白细胞骨架调节过程的不同方面,包括a)Rho-fa 微小GTPases (Rho,Rac 和Cdc42)的调节活性, B)肌动蛋白结合蛋白(例如,VASP [血管舒张兴奋剂的UI Ated磷蛋白]),C)激酶间接地控制肌动蛋白结合蛋白(的作用例如,P21活化激酶)和d)肌球蛋白(豪,2004) 。但是,PKA和其他激酶也可以通过磷酸化调节其他蛋白质,目前尚不知道。

有M 的UI ...

Comments